期刊文献+

子宫内膜癌雌激素受体α、β亚型和孕激素受体mRNA表达与临床病理的关系 被引量:6

Analysis of Estrogen Receptor α 、Estrogen Receptor β and Progesterone Receptor in Endometrial Carcinoma and Its Clinicopathologic Feature
下载PDF
导出
摘要 目的:探讨子宫内膜癌雌激素受体亚型ERα、ERβ和孕激素受体(PR)与临床病理特征的关系。方法:应用半定量逆转录聚合酶链反应(RT-PCR)检测50例子宫内膜癌组织中的ERα、ERβ和PRmRNA的表达,并结合患者的临床病理资料进行综合分析。结果:①50例子宫内膜癌组织中,ERαmRNA阳性表达率为74%(37/50),平均相对表达量为0.5279±0.1295;ERβmRNA阳性表达率为48%(24/50),平均相对表达量为0.3025±0.1687;PRmRNA阳性表达率为94%(47/50),平均相对表达量为0.6983±0.2864;ERα的表达率和平均相对表达量均比ERβ高(P<0.01)。②子宫内膜样腺癌中的ERα、ERβmRNA的阳性表达率大于其他组织学类型(P<0.05),ERα和PRmRNA的相对表达量在子宫内膜样腺癌组织中均大于其他组织学类型(P<0.05)。③ERα和PRmRNA相对表达量随组织学分级的增高而降低(P<0.05);ERβmRNA则无此变化。④PRmRNA的相对表达量随手术病理分期的增高而显著降低(P<0.01),ERα和ERβmRNA的表达无此变化。结论:ERα、ERβ和PRmRNA在子宫内膜癌的异常表达与子宫内膜癌的组织学类型、组织学分级和手术病理分期有关,可作为子宫内膜癌的预后和内分泌治疗的参考。 Objective:To explore the relationship between the expression of estrogen receptor alpha (ERα), estrogen receptor beta(ERβ)and progesterone receptor in endometrial carcinoma tissue and the clinicopathologic feature. Methods.. Using semiquantitive reverse transcription-polymerase chain reaction(RT-PCR), we examined the expression of ERα, ERβ and PR mRNA in 50 cases of endometrial carcinoma tissues. Results: (1) ERα, ERβ and PR mRNA were detected in 74 %, 48 % and 94 % endometrial carcinoma,respectively. The average expression quantity of ERα, ERβ and PR mRNA in endometrial carcinoma was 0. 5279 ± 0. 1295, 0.3025 ± 0. 1687 and 0. 6983 ± 0. 2864,respectively. The expression of ERa mRNA in endometrial carcinoma tissues significantly higher than ERβ mRNA(P〈0.01 ). (2)The positive rate of ERα and ERβ were higher in Endometrioid Adenocarcinoma than other histological subtypes(p〈0. 05), respectively; While the average expression quantity of ERα and PR were higher in Endometrioid Adenocarcinoma than other histological subtypes(p〈0. 05), respectively. (3) Higher ERα and PR mRNA expression significantly correlated with histological grade(p〈0.05). (4) Higher PR mRNA expression significantly correlated with the clinical-surgical stage (p〈0.05). Conclusion: The abnormal expression of ERα,ERβ and PR was closed related to histological subtype ,clinical-surgical stage and histological grade. Therefore, they maybe helpful for the diagnosis and endocrine therapy of Endometrial caocinoma.
出处 《中国临床医学》 北大核心 2008年第6期863-865,共3页 Chinese Journal of Clinical Medicine
关键词 子宫内膜癌 雌激素受体亚型 孕激素受体 半定量逆转录聚合酶链反应 Endometrial carcinoma Estrogen receptor subtype Progesterone receptor Semi-quantitive RT-PCR
  • 相关文献

参考文献7

  • 1Rose PG. Endometrial carcinorna[J]. N Engl J Med, 1996,335: 640-649.
  • 2Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women[J].Int J Cancer, 2004.108:425-432.
  • 3范剑虹,吴霞,何陈云.中晚期宫颈癌的同步放化疗[J].中国临床医学,2006,13(6):983-984. 被引量:17
  • 4Junichi K, Takemi O, Hironori K, et al. Expression levels of estrogen receptor-α, estrogen receptorS, coactivators, and core pressors in breast cancer[J] . Clinical Cancer Research, 2000, 6:512-518.
  • 5Mylonas I. Jeschke U, Shabani N,et al. Normal and malignant human endometrium express irnmunohistochemically estrogen receptor alpha (ER alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR)[J]. Anticanccr Res, 2.005.25(3A):1679-1686.
  • 6Wen C, Juliette R, Michele T,et al. Expression levels of estrogen receptor beta are modulated by components of the molecular clock[J].MolCell Biol,2008,28(2):784-793.
  • 7All SH, Odonnejj AI., Balu D. et al. Estrogen receptor- alpha in the inhibition of cancer growth and angiogenesis[J]. Cancer Res. 21)00,60(24):7094-7098.

二级参考文献7

  • 1柯晓慧,孙杭临.晚期宫颈癌同步放化疗的疗效观察[J].江西医药,2004,39(6):413-414. 被引量:2
  • 2Morris M,Eifel PJ,Lu J,et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer[J].N Engl J Med,1999,340:1137-1143.
  • 3Rein DT,Kurbacher CM,Breidenbach M,et al.Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer:a phase I study[J].Gynecologic Oncology,2002,87(1):98-103.
  • 4Whitney CW,Sause W,Bundy BN,et al.A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages ⅡB-ⅣA carcinoma of the cervix with negative paraaortic lymph nodes,A gynecologic oncology group and southwest oncology group study[J].J Clin Oncol,1999,17:1339-1348.
  • 5Rose PG,Bundy BN,Watkins EB,et al.Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer:results of a randomized gynecology oncology group st udy[J].N Engl J Med,1999,340:1144-1153.
  • 6Field AL,Mature results of a phase trial of concomitant cisplatin pelvix radiotherapy for locally advanced squamous-cell carcinoma of the cervix[J].Gynecologic Oncology,1996,64:416.
  • 7妇科常见恶性肿瘤诊断与治疗规范(草案)[J].中华妇产科杂志,1998,33(12):749-760. 被引量:34

共引文献16

同被引文献39

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部